Intimation of Closure of Trading Window for the Quarter and Half Year ending September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Limited has informed the BSE that its trading window will remain closed starting October 1, 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will reopen 48 hours after the company declares its Unaudited Financial Results for the quarter and half year ending September 30, 2025 (Q2/H1 FY26). During this period, Directors, Designated Persons, connected persons, and their immediate relatives are prohibited from trading in the company's shares. The company has also updated the NSDL portal to freeze PANs of designated persons at the security level. The date of the Board Meeting to approve the financial results will be announced separately.
This is a routine regulatory compliance filing ahead of the upcoming Q2/H1 FY26 earnings announcement and is not a negative signal. Retail investors should expect the company to declare its half-yearly results in the coming weeks, and no insider transactions are disclosed in this filing.